Letter to Colorectal Disease: Resumption of elective colorectal surgery during COVID-19 and risk of death.

Kathryn McCarthy* (Corresponding Author), P.K. Myint, S. Moug, L. Pearce, P. Braude, A. Vilches-Moraga, J. Hewitt, B Carter, OPSOC group

*Corresponding author for this work

Research output: Contribution to journalLetter

Abstract

The ACPGBI have recently released recommendations for re‐starting elective colorectal surgery to address the concerns that significant numbers of patients have been deferred during this pandemic worldwide (1). It is a credit to the specialty that most units have managed to continue with urgent cancer surgery through the pandemic, with leading units undertaking 4 to 5 urgent cases per week . Despite this there is now a need to accommodate other patient groups who need colorectal surgery such as those with inflammatory bowel disease and others with benign colorectal conditions who have been placed on hold.
Original languageEnglish
Number of pages3
JournalColorectal Disease
Early online date29 Jul 2020
DOIs
Publication statusE-pub ahead of print - 29 Jul 2020

Fingerprint Dive into the research topics of 'Letter to Colorectal Disease: Resumption of elective colorectal surgery during COVID-19 and risk of death.'. Together they form a unique fingerprint.

  • Cite this

    McCarthy, K., Myint, P. K., Moug, S., Pearce, L., Braude, P., Vilches-Moraga, A., Hewitt, J., Carter, B., & OPSOC group (2020). Letter to Colorectal Disease: Resumption of elective colorectal surgery during COVID-19 and risk of death. Colorectal Disease. https://doi.org/10.1111/codi.15282